industry-sponsored symposium
16.30-17.30h - Management of Poor Responders: Exploring Therapeutic Considerations
Chairman:
Dr. Gaurang Daftary
Global Scientific Vice President, RMMH, Ferring Pharmaceuticals - The Poor Responder: Evolving our understanding
Dr. Christine Wyns
Head of the Cliniques Universitaires Saint-Luc's Gynaecology and Andrology Department
Medical Director of the Reproductive Tissue and Cell Bank.
Professor at Université Catholique de Louvain. - The Poor Responder: Protocol considerations
Dr. Juan Antonio García Velasco
Director of IVI Madrid.
Professor of Obstetrics and Gynaecology at Rey Juan Carlos University, Madrid, Spain. - The Poor Responder: Clinical Practice
Drs. Wyns & García Velasco
CHECH THE PROGRAM17.30-18.30h
The era of individual luteal phase support (iLPS) has begun
Chairman:
Joaquín Llácer
Medical Director Ginefiv-GeneraLife Spain
- Importance of progesterone levels during implantation
Dominique De Ziegler
University Consultant at Foch Hospital, France - Beyond implantation. Progesterone levels for maintenance of pregancy
Elena Labarta
Gynaecologist specialized in assisted reproduction. IVIRMA, Spain
CHECH THE PROGRAM18.30-19.30h
- Personalized Management of patients in reproductive medicine
Moderator:
Monica Lispi
GMA Merck - Speaking about success in Normoresponders
Dr. Filippo Ubaldi - Who may benefit of rLH?
Dr. Shahar Kol
CHECH THE PROGRAM- Management of Poor Responders: Exploring Therapeutic Considerations
16.30-17.30h
- How Artificial Intelligence could improve IVF utilizationWelcome
Chairman:
Nick Macklon - Overview of artificial Intelligence in Healthcare
Ignacio H. Medrano
Founder & Chief Medical Officer at SAVANA - Clinical integration into IVF of Artificial Intelligence and Machine learning
Ernesto Bosch
Medical Director IVIRMA Valencia - Conclusions
Chairman
Nick Macklon
CHECH THE PROGRAM17.30-18.30h
- Organon Introduction (10’)
Keith Gordon
Executive Global Director of Fertility Medical affairs in Organon (Chairman) - Customizing the approach of ovarian stimulation for every patient category
Christophe Blockeel
Medical Director Centre for Reproductive Medicine, UZ Brussel - Q&A (10’-15’)
CHECH THE PROGRAM18.30-19.30h
Why an electronic witnessing system is valued as an essential team player by both clinics and patients
Moderator: Karen Schnauffer- The Lab Managers perspective on why RI Witness should be considered a “team player” in the lab
Albert Obradors
Founder and Lab Director
FIV Obradors - The patient perspective on the benefits of an electronic witnessing system
Stephen Troup
Consultant Reproductive Scientist
CHECH THE PROGRAM- How Artificial Intelligence could improve IVF utilizationWelcome